For the year ending 2025-12-31, GOSS made $48,471,000 in revenue. -$176,708,000 in net income. Net profit margin of -364.56%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 48,471,000 | |||
| Research and development | 174,093,000 | |||
| In process research and development | 7,475,000 | |||
| General and administrative | 37,631,000 | |||
| Total operating expenses | 219,199,000 | |||
| Loss from operations | -170,728,000 | |||
| Interest income | 1,970,000 | |||
| Interest expense | 10,989,000 | |||
| Other income, net | 9,289,000 | |||
| Total other income, net | 270,000 | |||
| Loss before provision (benefit) for income taxes | -170,458,000 | |||
| Provision (benefit) for income taxes | -88,000 | |||
| Net loss | -170,370,000 | |||
| Foreign currency translation | -6,248,000 | |||
| Unrealized income (loss) on marketable securities | -90,000 | |||
| Other comprehensive income (loss) | -6,338,000 | |||
| Comprehensive loss | -176,708,000 | |||
| Basic EPS | -0.75 | |||
| Diluted EPS | -0.75 | |||
| Basic Average Shares | 228,519,130 | |||
| Diluted Average Shares | 228,519,130 | |||
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)